Juvenescence: Investing in the Age of Longevity
The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies
This new book by Jim Mellon and Al Chalabi is a layman's guide to longevity. It investigates the new technologies and explains how to benefit from the life extending technologies both personally and professionally. It helps readers unravel the science, offers ideas on potential investment and reveals the views of the key opinion leaders.
Visit website: https://www.juvenescence-book.com/
See also: 
Jim Mellon
- British entrepreneur, author and philanthropist with interests across a number of industries
Juvenescence: Investing in the Age of Longevity is also referenced in the following:
ARDD 2021 - 8th Aging Research and Drug Discovery Meeting
31-Aug-2021 to 03-Sep-2021
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
Juvenescence: Investing in the Age of Longevity News
Interview with Juvenescence author Jim Mellon
Medium - 17-May-2018
Juvenescence Ltd is making investments in the future of rejuvenation and life extension technology
Read more...British billionaire gambles on an anti-aging upstart
Endpoints News - 26-Jul-2017
We are at an inflection point for the treatment of aging. We can generate molecules with specifi...
Read more...Billionaire Jim Mellon invests in anti-ageing research firm
pharmaphorum - 11-Apr-2017
Insilico Medicine applying big data analytics to extend healthy longevity. pursuing internal dru...
Read more...
